HealthQuill Thrombosis
Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion to expand its cardiovascular pipeline.
Uncategorized

Switzerland’s Novartis to buy US-based Anthos for $3.1 billion

Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion.

Read More
Humacyte Global, Inc., a US-based bioengineering company, got the US regulator’s nod for its product Symvess, a surgical implant to replace a patient’s damaged blood vessel after a traumatic injury.
Drugs Health Medical Pharma

Humacyte’s tissue-engineered blood vessel for vascular trauma gets nod

Humacyte Global, Inc., a US-based bioengineering company, got the US regulator’s nod for its product Symvess, a surgical implant to replace a patient’s.

Read More